What profile is used for determination of risk of coronary artery disease?

What profile is used for determination of risk of coronary artery disease?

• A. Comprehensive metabolic profile
• B. Lipid profile
• C. HbA1c
• D. Liver function panel

Answer: (B)

The main idea is that cholesterol and other fats measured by a profile directly reflect the risk of plaque buildup in the arteries, which underlies coronary artery disease. A lipid profile evaluates total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. High LDL or low HDL, or elevated triglycerides, indicate greater atherosclerotic risk and help clinicians estimate a patient’s chance of developing CAD and guide treatment decisions, such as lifestyle changes or lipid-lowering therapy. The other profiles look at different systems or conditions. A comprehensive metabolic profile screens organ function and metabolic status but doesn’t specifically quantify lipid-related CAD risk. HbA1c reflects long-term glucose control and diabetes risk, which is a CAD risk factor but not a direct measure of lipid-related risk. A liver function panel checks liver enzymes and related functions, not CAD risk.

The main idea is that cholesterol and other fats measured by a profile directly reflect the risk of plaque buildup in the arteries, which underlies coronary artery disease. A lipid profile evaluates total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. High LDL or low HDL, or elevated triglycerides, indicate greater atherosclerotic risk and help clinicians estimate a patient’s chance of developing CAD and guide treatment decisions, such as lifestyle changes or lipid-lowering therapy.

The other profiles look at different systems or conditions. A comprehensive metabolic profile screens organ function and metabolic status but doesn’t specifically quantify lipid-related CAD risk. HbA1c reflects long-term glucose control and diabetes risk, which is a CAD risk factor but not a direct measure of lipid-related risk. A liver function panel checks liver enzymes and related functions, not CAD risk.